Dr.Jason McLellan's groundbreaking research on viral and bacterial proteins has led to the development of vaccines and treatments for deadly pathogens affecting billions of people. His co-invention of a method for engineering a crucial protein in coronaviruses has played a key role in the COVID-19 vaccine development, including those from Pfizer/BioNTech, Moderna, Johnson & Johnson, and Novavax.
McLellan, a former assistant professor at the Geisel School, is now the Robert A. Welch Chair in Chemistry at the University of Texas at Austin.